© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Back in the late 1970s and early 1980s, scientists hunting for ways to clean up DNA and RNA contamination ran into brick walls in protein purification. The mess left behind by nucleic acid fragments often threw a wrench into downstream biological research and biotechnology production. Early enzymes from animal sources barely cut it with inconsistency, purity issues, and limited scalability. When recombinant DNA technology started maturing, researchers finally managed to clone and express endonucleases from Serratia marcescens in microbial systems. This breakthrough opened the door for large-scale, consistent, high-purity nuclease production. Benzonase Nuclease became a household name in labs through the 1990s, trusted for its ability to chop up nucleic acids in everything from cell lysates to industrial vaccine prep. The production no longer depended on animal tissue but leaned on well-controlled fermentation, leaving fewer unwanted surprises for those working in diagnostics or drug manufacturing.
Many view Benzonase Nuclease Recombinant 5KU as a solution for those who hate the hassle nucleic acids cause. This enzyme acts fast, breaking down both DNA and RNA into small oligonucleotides, so samples stay clean in molecular biology, cell culture, and bioprocessing. Product formats usually come in vials or sealed glass containers, packed at activity levels rated in kilo-units—5K units handle most lab-scale or early stage industrial applications. The attention to recombinant production brings an assurance of animal-component free supply, reflected in both the trust regulators place in it for Good Manufacturing Practice (GMP) work and its broad adoption in companies making vaccines, monoclonal antibodies, and gene therapies.
Folks working long hours at the bench soon learn Benzonase isn’t sensitive to gentle handling—this clear, colorless liquid or lyophilized powder dissolves easily in a range of buffered salt solutions and retains its strength over a comfortable temperature range. The enzyme loves magnesium ions but loses punch fast without them. Molecular weight clocks in around 30 kDa, and it’s stable from pH 7 to 9. Those running SDS-PAGE find clean, distinct bands, a sign of real purity and reliable batch-to-batch reproducibility. Benzonase stands up well in fermentation environments and routine lab buffers, so users get consistent results whether prepping for mass spectrometry or stripping cell culture debris.
The label on Benzonase vials straight up lists product code, lot number, activity per vial (commonly 5,000 units), storage temperature, buffer composition, and any excipients like glycerol. Each unit gets pegged to the amount of enzyme that solubilizes 37 micrograms of DNA per minute at 37°C—most companies reference a standard assay using lambda DNA or similar. Certificates of Analysis always show purity levels—typically topping 99% by SDS-PAGE—and endotoxin content, backing up claims for compatibility with clinical and preclinical use. Enzyme activity profiles and certifications for being animal-origin free now drive purchasing decisions more than ever, especially in sensitive biologic production lines.
Laboratories and manufacturers turn to recombinant expression systems, usually using E. coli strains optimized for high secretion yields and vector systems loaded with the Benzonase gene. Harvested cells face lysis, then a mix of filtration, precipitation, and column chromatography clears out impurities. Downstream, a series of polishing steps brings up the purity to pharmaceutical grade. To keep things running smooth, the process includes strict documentation and in-line testing—one misstep leads to lost enzyme or, worse, faulty product. Teams must keep cell disruption uniform, maintain cold temperatures, and check activity at every stage, which helps avoid big losses later in the process.
Benzonase chews up nucleic acids by hydrolyzing phosphodiester bonds, producing small fragments around 2 to 5 base pairs. The enzyme works without prejudice, breaking both double- and single-stranded DNA and RNA, and doesn’t stop midway unless chelated by EDTA or similar agents depriving it of magnesium. Folks working with labeled or engineered substrates leverage this property in quality control—generating fingerprint-like patterns verifying the enzyme lots function as expected. Covalent modifications like PEGylation or using fusion tags help in industrial cases where stability, re-use, or immobilization on beads saves time and costs at scale. Adaptations mostly target process stability and extending shelf life rather than changing specificity, which rarely needs tweaking for downstream uses.
You’ll hear Benzonase called by many names across patents, catalogs, and lab meetings: Endonuclease, Serratia marcescens nuclease, Nuclease S, or even branded variations unique to a supplier. In the market, companies led by Merck-Millipore, Sigma-Aldrich, and others use proprietary branding alongside generic references to hint at enhancements or sourcing, though the core enzyme maintains the same signature activity.
Benzonase doesn’t act on proteins or other cell components, so chemical risks remain low for those handling it under routine circumstances, but enzymes sometimes sensitize skin or cause allergic reactions, so glove and goggle use stays standard. Good lab practice teaches users to avoid aerosolizing powders and to store cold to prevent slow breakdown—few things upset a production manager more than a ruined batch from enzyme decay. Documentation coming from manufacturers includes thorough microbial purity testing, endotoxin checks, and residual activity calculations, directly tied to quality control protocols and batch release criteria in regulated spaces. Bench users follow basic chemical hygiene and rely on local exhaust ventilation when handling bulk enzyme in powder form.
Benzonase’s versatility fits global needs. Protein purification, cell culture clarification, removal of host-cell DNA in biopharmaceutical processes, and prepping samples for next-gen sequencing all rely on its speed and thoroughness in breaking up nucleic acids. Labs cleaning up viral vector prep or setting up high-throughput genomic pipelines like using Benzonase, since its rapid turnover prevents column fouling and false reads from nucleic acid clutter. Scenarios such as extracting antibodies, prepping vaccines, or ensuring sample sterility prior to mass spectrometry rely on its non-specific activity. Even emerging CRISPR workflows and synthetic biology projects slot Benzonase in for clearing DNA at interim stages, showing the enzyme’s grip on both established and future-facing research.
With tighter purity standards and regulatory demands, R&D around Benzonase now focuses on making more robust, higher-yield versions, tweaking the enzyme’s structure for faster production and easier downstream filtration. Protein engineers keep exploring changes at the molecular level—targeted mutagenesis offers a path to variants with custom stability profiles for exotic processing conditions (like temperature extremes or alternative buffer systems). Automation and high-throughput screening guide next-gen strains that push out even higher levels of enzyme with fewer by-products, cutting down both time and costs for those in industrial manufacturing. Collaboration between academic labs and industry keeps pushing the boundaries, blending protein science with practical manufacturing knowledge.
A huge focus falls on establishing Benzonase’s safety in the environments it touches, from industrial reactors to diagnostic labs and therapeutic manufacturing. Animal-free status helped Benzonase move into clinical pipelines, but companies and regulatory bodies keep churning out reports documenting absence of off-target effects, allergenicity, or toxicity when exposure comes from trace amounts in finished bioproducts. Studies have shown that degradation fragments do not pose risk at residual levels present in pharmaceuticals or research settings. Even so, teams routinely run in vitro and in vivo toxicity checks, and a constant re-evaluation keeps up with new applications, especially for gene therapy or next-in-line cell therapeutics.
Within the next decade, Benzonase and related nucleases face heightened demand from gene therapy, cell-based medicines, and next-generation vaccine platforms. As multi-step purification and CRISPR workflows expand, researchers will lean harder on nucleic acid removal to keep processes reliable and regulator-approved. More robust, designer variants with heightened thermostability, better resistance to shear stress, or broader compatibility with different buffers look set to enter the market. Manufacturing tracks longer-term supply chain security through synthetic biology or yeast-based expression instead of E. coli, hedging against bacterial phage risks and sustainability concerns. Benzonase Nuclease’s future looks locked in as a scientific workhorse—fine-tuned and optimized for the ever-growing, ever-changing needs of both research and industry.
Anyone who has tackled protein purification probably knows the headache of sticky, viscous cell lysates. DNA and RNA get chopped up during processing, but they linger in those samples. The solution? Benzonase Nuclease. This enzyme chews up nucleic acids fast—single-stranded, double-stranded, circular, it doesn’t care. Run a small experiment without it, and you’ll see the goo slow down your work, clog up filters, and muddy results. A clear lysate means less trouble downstream, especially for columns or bead-based purification. It saves time and lets you focus on getting the protein, not fighting the sample.
In my lab experience, resin clogging ranks high among lab annoyances. Plugged columns slow everyone down. Adding Benzonase Nuclease solves this. Elimination of nucleic acid debris takes pressure off purification steps. That smooth flow transforms the process for researchers working with bacterial or mammalian cells. Beyond getting a cleaner prep, it guards the machinery—columns, pumps, tubing stay in service longer, and maintenance costs drop. That’s real value for anyone running expensive gear.
Biopharma doesn’t just worry about clogged lines; regulators care about residual DNA in therapeutic and vaccine products. That’s not a minor detail—for human therapeutics, the FDA and EMA require the DNA content to stay well below set limits. Benzonase Nuclease (recombinant grade) lets drug manufacturers shred DNA fast, bringing those numbers down. Some audits call for proof that DNA was destroyed, and labs need data to back it up. This enzyme, produced without using animals or infectious agents, fits GMP manufacturing requirements and gets regular use in the industry’s cleanrooms.
I’ve met scientists who have watched whole batches of product go to waste because of contamination. Benzonase Nuclease gives more than just convenience; it offers peace of mind. Consistency matters, especially with biologics. Without DNase treatment, trace amounts of nucleic acid might make it into finished products. That can mean immune reactions or interference during analysis. By knocking down genetic contaminants, Benzonase Nuclease adds a level of certainty—and that keeps therapies safer for people who need them most.
It’s not only about regulations or science—time really does mean money in biotech. Crude preps slow up scaling, and time lost clearing DNA by old, clunky means (like physical shearing or precipitation) kills momentum. In my work, adding recombinant 5KU Benzonase cut down our process by hours—sometimes days. That kind of cut pays for itself and makes teams more productive. Labs avoid rerunning failed samples, and projects move from bench to market much faster.
Trust forms a foundation in both research and medicine. The science behind Benzonase Nuclease comes with years of published results and peer review. Using enzymes built by recombinant techniques reduces risk compared to animal-sourced options, a shift the industry widely supports. Between compliance, efficiency, and safety, this enzyme keeps showing up as a must-have. For most researchers facing the stubborn mess of DNA, few tools offer the same return on investment, reliability, and assurance.
My lab years taught me that a little oversight during storage can turn a good enzyme into a useless bottle of liquid. Benzonase Nuclease (Recombinant 5KU) is an enzyme that chews up unwanted DNA and RNA in protein prep, cell lysis, and other molecular biology work. If you don’t respect the storage rules, you lose money and derail experiments.
Enzymes, especially recombinant ones like this, behave a lot like milk. Leave it out too long, and you regret it the next day. Benzonase Nuclease runs best at -20°C, deep in the freezer. Stick it on the lab bench, warm it up repeatedly, or forget it in a fridge over the weekend, and activity drops—sometimes by half or more, ruining hard-earned sample prep.
Manufacturers prep the enzyme for freezing. You won’t see ice crystals or separation in a good product; the liquid looks clear, maybe slightly viscous. Keep the cap screwed tight. Moisture or airborne contaminants can sneak in and damage the enzyme. If the only freezer space is frost-laden and unreliable, enzyme performance slips away. One study found enzyme activity declined almost 20% in just a month at 4°C, compared to negligible loss staying at -20°C.
Enzyme price tags sting, so make the purchase last. I always grab single-use aliquots on day one. That way, you never put a half-empty tube back in the freezer. Repeated freeze-thaw cycles chip away at enzyme purity and punch holes in your wallet. Aliquot small volumes—enough for a day or a week—into clean microcentrifuge tubes. Label them clearly with date and concentration. Fresh gloves and clean pipette tips matter.
You spot cloudy liquid, odd-smelling tubes, or crust on the inside of the cap: toss it. These changes point to contamination or breakdown. Once, a teammate tried blaming buffer error for faint protein bands. Turns out, his Benzonase spent two days at room temperature because someone unplugged the lab fridge. Lesson learned.
Labs can be chaotic. Power outages, crowded freezers, or staff turnover all challenge safe storage. In my experience, investing a bit in backup systems pays off. Temperature loggers or alarms for freezers catch issues early. Sharing a labeled inventory sheet next to the freezer door helps keep everyone honest and reduces accidental warming. Some suppliers even ship Benzonase with stabilizers—great for shipping but still no excuse to leave it out after arrival.
If you inherit an old batch, check with the supplier about storage records or activity tests. Don’t gamble with precious reagents. I’ve learned to budget for a new bottle at the start of a big project. Over time, these habits save money and stress. Reliable storage isn’t glamorous, but every successful DNA-free protein prep relies on it.
Training new team members on enzyme care pays off fast. Simple habits, like recapping tubes immediately and using aliquots, save hours and keep experiments reproducible. In tight-budget labs, pooling orders and using shared protocols ensures everyone gets what they need without cutting corners.
Proper storage isn’t just a technicality—it's the backbone of reliable science. Take care of Benzonase Nuclease, and it’ll take care of your experiment.
Most lab folks, including those running regular protein preps or trying to cut through stubborn DNA tangles, turn to Benzonase Nuclease to get the job done. This enzyme chews up all forms of nucleic acids, making it a must-have when prepping samples for downstream protein work or cleaning up high-viscosity lysates. But there’s always that question in the lab—how much do you really need? Rumors fly, stock solutions sit in freezers, but few talk about their actual experience beyond quoting datasheets.
Going by what I’ve seen and handled, scientists often use Benzonase Nuclease at concentrations between 25 to 250 units per milliliter of reaction volume. While the upper range works for really sticky samples or big volumes that need quick action—say, large-scale E. coli lysis—the lower end covers most lysate preps for protein purification or virus removal. Sales sheets and protocols usually pitch the 1 unit per microliter, but real-world samples, especially those with lots of DNA, call for a bit more punch.
Too little enzyme leaves behind nucleic acids, gumming up your columns and sample tubes. Too much just wastes money or risks gnawing away at sensitive recombinant proteins. Here’s the sweet spot: For most common buffer preps, a working concentration of 25–50 units/mL clears out background DNA and RNA without overkill. For high-density samples—like cells harvested from bioreactors or mammalian cell lysates—upsizing to 100–250 units/mL usually clears viscosity fast, keeping those downstream purifications smooth.
Personal mishaps prove this point. Adding the minimum to an E. coli lysate once slowed down my later nickel column run, as the DNA never broke down fully. Doubling the enzyme cleared it up, and the next prep ran clean. It’s a classic: assay, adjust, and always have more in reserve, since everything from salt to the presence of protease inhibitors can mess with Benzonase activity.
Manufacturers provide broad recommendations, but journals back up the need for flexibility. A study published in Protein Expression and Purification showed that 25 units/mL works for most small-scale His-tag preps. For virus removal, the Journal of Virological Methods recommends 125–250 units/mL, especially in tough matrices like culture supernatants.
It’s easy to forget factors lurking in the background. EDTA can shut down Benzonase as its metal-dependent activity relies on magnesium ions. Overloading proteins or other contaminants can shield DNA, so sometimes even higher concentrations make sense.
For first-timers or those troubleshooting sticky preps, starting at 50 units/mL offers a solid baseline. Scale up if viscosity or nucleic acid smears persist after 20–30 minutes at room temperature. Always make sure lysis buffers include magnesium to keep the nuclease in top form. Filtering reagents and prepping fresh stocks make a difference, as old solutions can lose activity faster than advertised.
Anyone looking to cut costs can test smaller amounts batch by batch, since excessive Benzonase use eats through budgets fast. Still, it’s better to spend a few extra units than to lose an entire prep. If tangled DNA keeps clogging up your workflow, up your dose and check your buffer. The right enzyme level turns sample prep from a headache into something as routine as pipetting.
Every scientist I know who works with sensitive cell cultures or protein purification keeps a short list of products they absolutely trust. On that list, Benzonase Nuclease, especially the recombinant 5KU form, often gets a nod. This enzyme clears away nucleic acids rapidly, which streamlines workflows and bumps up yields. Before dropping the reagent into a mix, though, the main question that nags at any bench scientist is: just how clean is it? Are there endotoxins or sneaky contaminants tagging along?
Endotoxins come from the outer wall of gram-negative bacteria. These molecules can wreck a perfectly planned experiment, setting off immune responses, messing with mammalian cell viability, or throwing purification accuracy out the window. No lab wants its results questioned because of an overlooked risk. In personal lab work, assays for pyrogen contamination have stopped more than one promising project in its tracks.
Manufacturers know these risks. For recombinant enzymes like Benzonase Nuclease, production usually takes place in E. coli—a bacteria that sheds endotoxins by default. That means every batch has to go through intensive purification, including techniques like ion-exchange and affinity chromatography. Only active oversight and careful design strip out the endotoxins enough for consistently high-grade enzyme prep. Most reputable suppliers run Limulus Amebocyte Lysate (LAL) tests, aiming for well below 0.1 EU/µL, because higher levels spark red flags in cell therapy and vaccine applications.
It’s not only endotoxins that are a headache. Sometimes you get leftover DNA, proteases, or even buffer salts riding along in an enzyme prep. If those slip through, workflows grind down with weird bands on gels or unexpected protein cleavage. The best suppliers don’t just stop at one purification step—they add in size exclusion, precise filtration, or even mass spec checks to keep enzymatic activity high and contaminant levels down.
A seasoned lab hand learns to ask for detailed quality control sheets. Chromatograms, protein sequencing data, and certificate of analysis (COA) documentation separate the reliable batches from products that might disrupt high-stakes therapeutics or diagnostics. Some companies publish their whole testing process, highlighting not only endotoxin levels but also residual host DNA, RNase, and protease screening. I’ve seen major funding decisions ride on whether those specs match published claims.
Trust but verify—scientists end up living by this philosophy. A well-vetted batch of recombinant Benzonase goes a long way to clearing up results, saving money, and protecting downstream processes. Still, no purification system is bulletproof. Raw material sourcing, facility hygiene, and instrument calibration all shape the outcome. Even seasoned labs have run “blank” LAL tests and picked up low-level contamination from bottles or pipette tips.
Open communication between buyers and suppliers turns out to be one of the simplest defenses. Routine batch verification, blinded sampling, and writing clear expectations into contracts keep standards high. Training newer lab members to recognize the signs of contamination—cell death, odd bands, low yields—makes a difference over time. And if a supplier ever hesitates to share detailed specs or quality numbers, the safest move is to look elsewhere for critical reagents.
Every generation of researchers grows a little stricter with product scrutiny because science keeps raising the stakes. Endotoxin checks, regular method validation, and direct coordination between vendors and end users remain the backbone for clean biotech workflows. Benzonase Nuclease, in recombinant 5KU form, earns its keep in labs that demand reliability—provided nobody skips the hard conversations about contamination and transparency.
Benzonase Nuclease works like a cleanup crew for DNA and RNA in labs. Anyone who’s tried to purify proteins knows the sticky mess that nucleic acids can cause. This enzyme chops up both DNA and RNA, clearing the way for downstream work. But if you don’t match your conditions to the enzyme’s preferences, you risk wasting time and money on poor results.
Benzonase Nuclease shows peak activity at a pH between 8.0 and 9.0. Labs run most protein purifications near neutral, but nudging towards slightly alkaline ranges lets this enzyme do its best work. Below pH 8, activity slows, and anything too basic (above pH 10) starts to hit both your protein interest and the enzyme's own stability. For temperature, 37°C stands as the sweet spot. Most protocols stick close to this warmth, mirroring the body’s natural setting. Heat rises much above 40°C and the enzyme starts to unravel, losing punch and putting results at risk.
I remember running my first benzonase test, under tight deadlines before a group meeting. I stuck to a buffer around pH 7 and set the water bath at 25°C, figuring “close enough.” The enzyme barely made a dent on the nucleic acid contamination. After digging into technical notes, I made the switch: bumped Tris-HCl buffer to pH 8.5, cranked incubations to 37°C, and saw dramatic improvement. Gel analysis after treatment was suddenly clean, protein yield improved, and downstream work wasted less time on gunky samples.
This isn’t just a personal story. Independent studies back these conditions. For instance, Merck’s technical documents say Benzonase Nuclease works best at pH 8.0–9.2 and 37°C, using a buffer like 50 mM Tris-HCl with 1–2 mM MgCl2. Some people push to pH 9, especially if they have high DNA loads, but most find the magic just above pH 8.
No talk about Benzonase Nuclease works without a word on magnesium. It acts as a cofactor—the enzyme won’t do much without it. A range of 1–2 mM magnesium chloride stays standard. Skipping it even once turns your digestion into a no-show. I missed this detail once, and the difference between a functioning and a limp reaction couldn’t be clearer.
Buffer prep runs into surprises. Contaminated water, off-the-shelf buffers with hidden additives, or overlooked stocks bring swings in pH or ion concentrations. Small slip-ups, like using stale MgCl2, hit results hard. Regular calibration matters. For folks who need DNase-free or RNase-free environments, using Benzonase often solves both in one go, but only if you stick to its optimal range.
If you can't run at 37°C, expect slower progress. Some use longer incubations at room temperature, but the enzyme works best in its comfort zone. Labs focused on cold-room work might need to weigh results against speed. Chasing a pure prep means sticking close to these key conditions.
Good science means working with, not against, biological tools. Keeping Benzonase Nuclease at pH 8.0–9.0, paired with 37°C and fresh magnesium, consistently brings success. I’ve seen over and over that careful, attentive prep outpaces expensive fixes or shortcuts. Mastering these basics pushes research forward and saves resources for bigger experiments down the line.
| Names | |
| Preferred IUPAC name | Deoxyribonuclease 1 |
| Other names |
Endonuclease Nuclease Serratia marcescens Nuclease |
| Pronunciation | /ˈbɛnzəˌneɪs ˈnjuː.kli.eɪs rɪˈkɒm.bɪ.nənt faɪv ˈkeɪ ˈjuː/ |
| Identifiers | |
| CAS Number | 82657-50-1 |
| Beilstein Reference | 3587152 |
| ChEBI | CHEBI:22215 |
| ChEMBL | CHEMBL3341126 |
| DrugBank | DB01301 |
| ECHA InfoCard | 03f2cc8e-0516-42a1-8704-08a3457b8ea8 |
| EC Number | 3.1.30.2 |
| Gmelin Reference | 16604 |
| KEGG | C14431 |
| MeSH | D000072897 |
| PubChem CID | 10480354 |
| RTECS number | DB8225000 |
| UNII | 6U8ST1O13E |
| UN number | UN3316 |
| Properties | |
| Chemical formula | C27H39N9O6 |
| Molar mass | 30 kDa |
| Appearance | Clear, colorless to slightly yellow solution |
| Odor | Odorless |
| Density | 0.95 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.7 |
| Basicity (pKb) | 7.63 |
| Magnetic susceptibility (χ) | -13.0 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.100 |
| Viscosity | Low |
| Dipole moment | 177.81 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 219.1 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | V03AB27 |
| Hazards | |
| Main hazards | Harmful if inhaled. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS05 (Signal word: Danger) |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H315: Causes skin irritation. H319: Causes serious eye irritation. H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335: May cause respiratory irritation. |
| Precautionary statements | P280, P305+P351+P338, P302+P352, P337+P313 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: - |
| LD50 (median dose) | >5000 mg/kg (rat, oral) |
| PEL (Permissible) | PEL (Permissible): Not established |
| REL (Recommended) | 4-8 U/mL |
| IDLH (Immediate danger) | Not Established |
| Related compounds | |
| Related compounds |
Benzonase Endonuclease DNase I MNase (Micrococcal Nuclease) RNase A Serratia marcescens Nuclease Turbo DNase Benzonase Nuclease HC Universal Nuclease OmniCleave Endonuclease |
